AnalystsTiago FauthTiago Fauth's Stock Forecasts
AnalystsTiago Fauth
Sectors:
Analyst Ranking
Bottom 5%
#4666 out of 4906 analysts
Average Return
-5.04%
Win Rate
37%45 out of 121
Risk vs Reward
Poor
Good
Tiago Fauth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Absci CorpABSI | +312.39% | $1.17 | $4.83 | 2023-05-16 - 2024-05-15 | Buy |
Prometheus Biosciences IncRXDX | +299.88% | $48.39 | $193.50 | 2022-08-12 - 2023-04-18 | Buy |
Verona Pharma PLCVRNA | +199.25% | $30.81 | $92.20 | 2024-10-03 - 2025-06-13 | Strong Buy |
Insmed IncINSM | +185.52% | $26.72 | $76.29 | 2024-04-01 - 2025-03-31 | Strong Buy |
Alx Oncology Holdings IncALXO | +182.19% | $5.39 | $15.21 | 2023-03-10 - 2024-03-08 | Buy |
Tiago Fauth Analyst Color
Get additional color on Tiago Fauth's coverage of popular stocks
Tiago Fauth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Liquidia CorpLQDA | 2 | Strong Buy | $25.00 | +77.30% | Maintains | 3 days ago |
Insmed IncINSM | 4 | Strong Buy | $119.00 | +20.53% | Maintains | 4 days ago |
Savara IncSVRA | 2 | Strong Buy | $7.00 | +216.74% | Maintains | 18 days ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $74.00 | +44.36% | Maintains | 19 days ago |
Inozyme Pharma IncINZY | 3 | Hold | $4.00 | +0.25% | Downgrades | a month ago |
Verona Pharma PLCVRNA | 5 | Strong Buy | $107.00 | +16.05% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 5 | Hold | $314.00 | +10.82% | Downgrades | 2 months ago |
Tectonic Therapeutic IncTECX | 4 | Strong Buy | $101.00 | +361.40% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 5 | Hold | $287.00 | -6.82% | Maintains | 3 months ago |
Pliant Therapeutics IncPLRX | 2 | Hold | $3.00 | +117.39% | Maintains | 3 months ago |
Keros Therapeutics IncKROS | 6 | Strong Buy | $26.00 | +91.74% | Maintains | 4 months ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $17.00 | +181.92% | Maintains | 4 months ago |
Ultragenyx Pharmaceutical IncRARE | 7 | Strong Buy | $88.00 | +134.73% | Maintains | 6 months ago |
Mannkind CorpMNKD | 1 | Strong Buy | $9.00 | +142.59% | Initiates Coverage On | 6 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $22.00 | +216.55% | Maintains | 8 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $75.00 | +39.64% | Initiates Coverage On | 10 months ago |
Jade Biosciences IncJBIO | 2 | Hold | $70.00 | +935.50% | Downgrades | a year ago |
Ventyx Biosciences IncVTYX | 5 | Buy | $62.00 | N/A | Maintains | 2 years ago |
Ascendis Pharma AASND | 13 | Hold | $89.00 | N/A | Assumes | 2 years ago |
Viridian Therapeutics IncVRDN | 3 | Buy | $51.00 | N/A | Assumes | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 7 | Buy | $120.00 | N/A | Assumes | 2 years ago |
23andme Holding CoMEHCQ | 6 | Buy | $120.00 | N/A | Reiterates | 2 years ago |
Immunovant IncIMVT | 4 | Sell | $4.00 | N/A | Reiterates | 2 years ago |
Vectivbio Holding AgVECT | 2 | Hold | $17.00 | N/A | Downgrades | 2 years ago |
Absci CorpABSI | 4 | Buy | $14.00 | N/A | Reiterates | 2 years ago |
Spruce Biosciences IncSPRB | 3 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Kura Oncology IncKURA | 5 | Buy | $26.00 | N/A | Reiterates | 2 years ago |
Abcellera Biologics IncABCL | 7 | Buy | $28.00 | N/A | Maintains | 2 years ago |
Apellis Pharmaceuticals IncAPLS | 9 | Hold | $81.00 | N/A | Maintains | 2 years ago |
Prometheus Biosciences IncRXDX | 5 | Hold | $200.00 | N/A | Downgrades | 2 years ago |
Humanigen IncHGENQ | 3 | Sell | $0.50 | N/A | Reiterates | 2 years ago |
Bioatla IncBCAB | 4 | Hold | $8.00 | N/A | Reiterates | 2 years ago |
Pyxis Oncology IncPYXS | 2 | Buy | $14.00 | N/A | Reiterates | 2 years ago |
Alx Oncology Holdings IncALXO | 2 | Buy | $34.00 | N/A | Maintains | 2 years ago |
Galecto IncGLTO | 2 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Exelixis IncEXEL | 1 | Buy | $29.00 | N/A | Initiates Coverage On | 2 years ago |
Omniab IncOABI | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 2 years ago |
Editas Medicine IncEDIT | 2 | Hold | $13.00 | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Inflarx NvIFRX | 3 | Sell | $2.00 | N/A | Maintains | 3 years ago |
Argenx SeARGX | 2 | Hold | $340.00 | N/A | Maintains | 3 years ago |
Iveric Bio IncISEE | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Buy | $98.00 | N/A | Maintains | 4 years ago |
Amgen IncAMGN | 1 | Buy | $259.00 | N/A | Maintains | 4 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $59.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.